Benzinga | Dec 9, 2021 09:46PM EST

Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $133

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $126 to $133.